Erdosteine
RESPIRATORY SYSTEM
Also known as: dithiosteine
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Erdosteine is a drug catalogued in DrugCentral. Recorded indications include Accidental poisoning by lead and its compounds and fumes and Mercury Toxicity.
- Indications: Accidental poisoning by lead and its compounds and fumes and Mercury Toxicity.
- ATC code: R05CB15 (Mucolytics).
- Molecular formula: C8H11NO4S2; molecular weight 249.30 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- Accidental poisoning by lead and its compounds and fumes
- Mercury Toxicity
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
R05CB15 | RESPIRATORY SYSTEM › COUGH AND COLD PREPARATIONS › EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS › Mucolytics |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Pneumonia | 53.9 |
Chemical structure
| Molecular formula | C8H11NO4S2 |
|---|---|
| Molecular weight | 249.30 g/mol |
| CAS number | 84611-23-4 |
| InChIKey | QGFORSXNKQLDNO-UHFFFAOYSA-N |
| PubChem CID | 65632 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Erdosteine used for?
DrugCentral lists the following indications for Erdosteine: Accidental poisoning by lead and its compounds and fumes and Mercury Toxicity.
What is the chemical formula of Erdosteine?
Erdosteine has the molecular formula C8H11NO4S2 and a molecular weight of 249.30 g/mol.
Browse: all drugs starting with E · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1041 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1697744 — compound record and bioactivity
- PubChem CID 65632 — chemical identifiers
- DrugBank DB05057 — drug record
- FDA UNII 76J0853EKA — substance identity
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.